AIM: To investigate which phosphodiesterase (PDE) is involved in regulating cyclic 3'5' guanosine monophosphate breakdown in retinal pigment epithelium (RPE) cells. METHODS: cGMP content in the cultured RPE cells (D407 cell line) was evaluated by immunocytochemistry in the presence of non-selective or isoform-selective PDE inhibitors in combination with the particulate guanylyl cyclase stimulator atrial natriuretic peptide (ANP) or the soluble guanylyl cyclase stimulator sodium nitroprusside (SNP). mRNA expression of PDE2, PDE5 and PDE9 was studied in cultured human RPE cells and rat RPE cell layers using non-radioactive in situ hybridisation. RESULTS: In the absence of PDE inhibitors, cGMP levels in cultured RPE cells are very low. cGMP accumulation was readily detected in cultured human RPE cells after incubation with Bay60-7550 as a selective PDE2 inhibitor, sildenafil as a selective PDE5 inhibitor or Sch51866 as a selective PDE9 inhibitor. In the presence of PDE inhibition, cGMP content increased markedly after stimulation of the particulate guanylyl cyclase. mRNA of PDE2,PDE5 and PDE9 was detected in all cultured human RPE cells and also in rat RPE cell layers. CONCLUSIONS: PDE2, PDE5 and PDE9 have a role in cGMP metabolism in RPE cells.
AIM: To investigate which phosphodiesterase (PDE) is involved in regulating cyclic 3'5' guanosine monophosphate breakdown in retinal pigment epithelium (RPE) cells. METHODS:cGMP content in the cultured RPE cells (D407 cell line) was evaluated by immunocytochemistry in the presence of non-selective or isoform-selective PDE inhibitors in combination with the particulate guanylyl cyclase stimulator atrial natriuretic peptide (ANP) or the soluble guanylyl cyclase stimulator sodium nitroprusside (SNP). mRNA expression of PDE2, PDE5 and PDE9 was studied in cultured human RPE cells and rat RPE cell layers using non-radioactive in situ hybridisation. RESULTS: In the absence of PDE inhibitors, cGMP levels in cultured RPE cells are very low. cGMP accumulation was readily detected in cultured human RPE cells after incubation with Bay60-7550 as a selective PDE2 inhibitor, sildenafil as a selective PDE5 inhibitor or Sch51866 as a selective PDE9 inhibitor. In the presence of PDE inhibition, cGMP content increased markedly after stimulation of the particulate guanylyl cyclase. mRNA of PDE2,PDE5 and PDE9 was detected in all cultured human RPE cells and also in rat RPE cell layers. CONCLUSIONS: PDE2, PDE5 and PDE9 have a role in cGMP metabolism in RPE cells.
Authors: Wilma C G Van Staveren; Harry W M Steinbusch; Marjanne Markerink-Van Ittersum; David R Repaske; Michael F Goy; Jun Kotera; Kenji Omori; Joseph A Beavo; Jan De Vente Journal: J Comp Neurol Date: 2003-12-22 Impact factor: 3.215
Authors: Frank G Boess; Martin Hendrix; Franz-Josef van der Staay; Christina Erb; Rudy Schreiber; Wilma van Staveren; Jan de Vente; Jos Prickaerts; Arjan Blokland; Gerhard Koenig Journal: Neuropharmacology Date: 2004-12 Impact factor: 5.250
Authors: E C La Heij; H G T Blaauwgeers; J de Vente; M Markerink; A T A Liem; A G H Kessels; H Steinbusch; F Hendrikse Journal: Br J Ophthalmol Date: 2003-11 Impact factor: 4.638
Authors: Diane T Stephenson; Tim M Coskran; Margaret B Wilhelms; Wendy O Adamowicz; Michele M O'Donnell; Kathleen B Muravnick; Frank S Menniti; Robin J Kleiman; Daniel Morton Journal: J Histochem Cytochem Date: 2009-06-08 Impact factor: 2.479
Authors: Roselie M H Diederen; Ellen C La Heij; Marijke A M Lemmens; Aize Kijlstra; Jan de Vente; Fred Hendrikse Journal: Mol Vis Date: 2008-02-04 Impact factor: 2.367